A gaggle of health-care businesses going public promises to make next week the busiest of the year for U.S. listings.
Ten companies — the most since November — are expected to price next week, with nine of them in the health-care sector, according to data compiled by Bloomberg that excludes special purpose acquisition companies, real estate investment trusts and funds.
The listings are on the small side, averaging about $84 million compared with $288 million for deals already priced this year.
Autolus Therapeutics Ltd., which is developing cancer therapies, is set to be the largest, with a targeted offering size of $133 million at the high-end of the marketed range. Magenta Therapeutics Inc. and Eidos Therapeutics Inc. follow, with both aiming to raise up to about $106 million.
Read on The Source